Outcome of total pelvic exenteration for primary rectal cancer

Diseases of the Colon and Rectum

Volumn 46, Issue 4, 2003, Pages 474-480

  Ike, Hideyuki ^a,b   Shimada, Hiroshi ^a   Yamaguchi, Shigeki ^a   Ichikawa, Yasushi ^a   Fujii, Shouichi ^a   Ohki, Shigeo ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

Lymph node metastasis; Prognostic factor; Rectal cancer; Total pelvic exenteration

Indexed keywords

CISPLATIN; FLUOROURACIL; MITOMYCIN C;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DEATH; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; HYDRONEPHROSIS; ILEAL CONDUIT; LENGTH OF STAY; LIVER DYSFUNCTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORBIDITY; MULTIVARIATE ANALYSIS; PANCREATITIS; PELVIS EXENTERATION; POSTOPERATIVE COMPLICATION; PREDICTION; PROGNOSIS; RECTUM CARCINOMA; RETROSPECTIVE STUDY; SEX DIFFERENCE; SMALL INTESTINE OBSTRUCTION; SURGICAL MORTALITY; TREATMENT OUTCOME; TUMOR LOCALIZATION; TUMOR VOLUME; URINARY TRACT INFECTION; WOUND INFECTION;

ADENOCARCINOMA; ADULT; AGED; FEMALE; HOSPITAL MORTALITY; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PELVIC EXENTERATION; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; REGRESSION ANALYSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0037390291     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10350-004-6585-2     Document Type: Article

References (43)

1. Lasser P, Doidy L, Elias D, et al. Total pelvic exenteration and rectal cancer. Apropos of 20 cases [in French]. Chirurgie 1999;124:252-7.
2. Jakowatz JG, Porudominsky D, Riihimaki DU, et al. Complication of pelvic exenteration. Arch Surg 1985; 120:1261-5.
3. Hafner GH, Herrera L, Petrelli NJ. Morbidity and mortality after pelvic exenteration for colorectal adenocarcinoma. Ann Surg 1992;215:63-7.
4. Luna-Perez P, Rodriguez DF, Flores D, Delgado S, Labastida S. Morbidity and mortality following preoperative radiation therapy and total pelvic exenteration for primary rectal adenocarcinoma. Surg Oncol 1995;4: 295-301.
5. Law WL, Chu KW, Choi HK. Total pelvic exenteration for locally advanced rectal cancer. J Am Coll Surg 2000; 190:78-83.
6. Odariuk TS, Tsarkov PV, Nechushkin MI, Rybakov EG. Is it possible to improve the quality of life of patients who have undergone pelvic evisceration? [in Russian]. Khirurgiia 1998;11:38-42.
7. Fuhrman GM, Talamonti MS, Curley SA. Sphincter-preserving extended resection for locally advanced rectosigmoid carcinoma involving the urinary bladder. J Surg Oncol 1992;50:77-80.
8. Osorio Gullon A, de Oca J, Lopez Costea MA, et al. Double-barreled wet colostomy: a safe and simple method after pelvic exenteration. Int J Colorectal Dis 1997;12:37-41.
9. Kato T, Nakazato H, Kato K. Normal values measurement of rectovaginal space and rectoprostatic space [in Japanese]. Nippon Daicho Komonbyo Gakkai Zasshi 1984;37:43-6.
10. Adam IJ, Mohamdee MO, Martin IG, et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 1994;344:707-11.
11. de Haas-Kock DF, Baeten CG, Jager JJ, et al. Prognostic significance of radial margins of clearance in rectal cancer. Br J Surg 1996;83:781-5.
12. Eckhauser FE, Lindenauer SM, Morley GW. Pelvic exenteration for advanced rectal carcinoma. Am J Surg 1979;138:412-4.
13. Boey J, Wong J, Ong GB. Pelvic exenteration for locally advanced colorectal carcinoma. Ann Surg 1982;195: 513-8.
14. Takagi H, Morimoto T, Yasue M, Kato K, Yamada E, Suzuki R. Total pelvic exenteration for advanced carcinoma of the lower colon. J Surg Oncol 1985;28:59-62.
15. Koyama Y, Moriya Y, Hojo K. Pelvic exenteration in advanced and or recurrent rectal cancer [in Japanese]. Nippon Geka Gakkai Zasshi 1987;88:58-62.
16. Lopez MJ, Kraybill WG, Downey RS, Johnston WD, Bricker EM. Extensive surgery for locally advanced rectosigmoid cancers. Is it worthwhile? Surgery 1987; 102:644-51.
17. Liu SY, Wang YN, Zhu WQ, Gu WL, Fu H. Total pelvic exenteration for locally advanced rectal carcinoma. Dis Colon Rectum 1994;37:172-4.
18. Wan Y, Xu W, Chen R. Total pelvic exenteration for local advanced rectal carcinoma: analysis of 20 patients. Zhonghua Wai Ke Za Zhi 1995;33:458-60.
19. Shirouzu K, Isomoto H, Kakegawa T. Total pelvic exenteration for locally advanced colorectal carcinoma. Br J Surg 1996;83:32-5.
20. Hida J, Yasutomi M, Maruyama T, et al. Results from pelvic exenteration for locally advanced colorectal cancer with lymph node metastases. Dis Colon Rectum 1998;41:165-8.
21. Verschueren RC, Mulder NH, Hooykaas JA, Szabo BG, Karrenbeld A. Pelvic exenteration for advanced primary rectal cancer in male patients. Clin Oncol (R Coll Radiol) 1998;10:318-21.
22. Chiesura-Corona M, Muzzio PC, Giust G, Zuliani M, Pucciarelli S, Toppan P. Rectal cancer: CT local staging with histopathologic correlation. Abdom Imaging 2000; 26:134-8.
23. Kwok H, Bissett IP, Hill GL. Preoperative staging of rectal cancer. Int J Colorectal Dis 2000;15:9-20.
24. Beets-Tan RG, Beets GL, Vliegen RF, et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 2001;357:497-504.
25. Kim NK, Kim MJ, Park JK, Park SI, Min JS. Preoperative staging of rectal cancer with MRI: accuracy and clinical usefulness. Ann Surg Oncol 2000;7:732-7.
26. Hunerbein M, Totkas S, Ghadimi BM, Schlag PM. Preoperative evaluation of colorectal neoplasms by colonoscopic miniprobe ultrasonography. Ann Surg 2000;232:45-50.
27. Garcia-Aguilar J, Pollack J, Lee S-H, et al. Accuracy of endorectal ultrasonography in preoperative staging of rectal tumors. Dis Colon Rectum 2002;45:10-5.
28. Papillon J. Surgical adjuvant therapy for rectal cancer: present options. Dis Colon Rectum 1994;37:144-8.
29. Ahmad NR, Nagle D. Long-term results of preoperative radiation therapy alone for stage T3 and T4 rectal cancer. Br J Surg 1997;84:1445-8.
30. Horie H, Kashiwagi H, Konishi F, Furuta K, Ozawa A, Kanazawa K. Improved outcome following preoperative radiochemotherapy: 40.5 Gy accelerated hyperfractionation and 5-fluorouracil suppositories for patients with carcinoma of the lower rectum. Surg Today 1999; 29:992-8.
31. Tjandra JJ, Reading DM, McLachland SA, et al. Phase II clinical trial of preoperative combined chemoradiation for T3 and T4 resectable rectal cancer: preliminary results. Dis Colon Rectum 2001;44:1113-22.
32. Sanfilippo NJ, Crane CH, Skibber J, et al. T4 rectal cancer treated with preoperative chemoradiation to the posterior pelvis followed by multivisceral resection: patterns of failure and limitations of treatment. Int J Radiat Oncol Biol Phys 2001;51:176-83.
33. Wust P, Rau B, Gellerman J, et al. Radiochemotherapy and hyperthermia in the treatment of rectal cancer. Recent Results Cancer Res 1998;146:175-91.
34. Herrera L, Brown MT. Prognostic profile in rectal cancer. Dis Colon Rectum 1994;37(Suppl):S1-5.
35. Meterissian SH, Skibber JM, Giacco GG, el-Naggar AK, Hess KR, Rich TA. Pelvic exenteration for locally advanced rectal carcinoma: factors predicting improved survival. Surgery 1997;121:479-87.
36. Gerard A, Berrod JL, Pene F, et al. Interim analysis of a phase III study on preoperative radiation therapy in resectable rectal carcinoma. Trial of the Gastrointestinal Tract Cancer Cooperative Group of the European Organization for Research on Treatment of Cancer (EORTC). Cancer 1985;55:2373-9.
37. Green JB, Timmcke AE, Mitchell WT, Hicks TC, Gathright JB Jr., Ray JE. Mucinous carcinoma - just another colon cancer? Dis Colon Rectum 1993;36:49-54.
38. Secco GB, Fardelli R, Campora E, et al. Primary mucinous adenocarcinomas and signet-ring cell carcinomas of colon and rectum. Oncology 1994;51:30-4.
39. Nozoe T, Anai H, Nasu S, Sugimachi K. Clinicopathological characteristics of mucinous carcinoma of the colon and rectum. J Surg Oncol 2000;75:103-7.
40. Ike H, Shimada H, Ohki S, Yamaguchi S, Ichikawa Y, Shouichi F. Return to social life after total pelvic exenteration for rectal cancer. Yokohama Med Bull 2002;49: 19-24.
41. Kusunoki M, Yanagi H, Shoji Y, Noda M, Ikeuchi H, Yamamura T. Reconstruction of the pelvic floor using absorbable mesh with bioresorbable membrane (Seprafilm) after abdominoperineal excision. J Surg Oncol 1999;70:261-2.
42. Balbay MD, Slaton JW, Trane N, Skibber J, Dinney CP. Rationale for bladder-sparing surgery in patients with locally advanced colorectal carcinoma. Cancer 1999;86: 2212-6.
43. Ike H, Shimada H, Fujii S, Kamimukai N, Ohshima T, Imada T. Extended abdominoperineal resection with partial prostatectomy for clinical stage T3 cancer of the lower rectum using the ultrasonic harmonic scalpel™. Hepatogastroenterology (in press).